Kuper, H., Adami HO and Trichopoulos D
Conclusion: Comprehensive GLP-1 Biosimilar Characterization is essential for ensuring the quality, safety, and regulatory acceptance of peptide therapeutics such as semaglutide and exenatide
Greater risk was confirmed for Wegovy versus Ozempic and for men versus women in multivariable regression (reporting odds ratios, 4.74 and 3.33, respectively)."These findings extend our prior global analysis and, whereas previous studies identified only an agent-specific association, this study provides the first evidence of a formulation- and dose-dependent ION risk, with the strongest association observed for Wegovy," the authors write.Abstract/Full TextEditorial.Sign up for our weekly HealthDay newsletter
Habits, support, and lifestyle changes matter just as much
I mean, if you have a neck injury, its kind of hard, just logistically to do, but when its your knee or in my case, I used it myself on a hamstring tear that I had, and theyre pretty easy to do on my own